Summary
In August 2008, the Ministry of Health and Family Welfare’s NACO developed an “Office Memorandum” in response to a public interest litigation (PIL), in which the Supreme Court reviewed the steps taken by NACO to combat HIV/AIDS and the services being provided to patients. The Supreme Court had issued directives, including those aimed at improving the sufficiency of centres distributing second line anti-retroviral therapy (ART).
Subsequently, Sankalp Rehabilitation Trust & ANR filed a writ petition challenging the criteria employed by NACO for administering ART for persons suffering from HIV/AIDS, specifically the extension of second line treatment to all patients who need it, regardless of whether they underwent first line treatment in private or government sector, and regardless of whether that first line treatment was rational. NACO consistently expressed that its ultimate goal was to have universal second line treatment. In proceedings before the Supreme Court, the parties discussed the modalities to bring about universal second line treatment to all those who need it.
On December 12, 2010, a meeting was held where several decisions regarding the steps to attain universal second line treatment were made. First, the Court ordered that all private practitioners be required to follow the ART guidelines set forth in the August 2008 Office Memorandum. Second, NACO committed to making second line treatment accessible to all those in need.
However, the Court recognized some constraints that would need to be immediately addressed. Lacking complete data on those who need second line treatment, a proposed “first phase” of initiation would start universal treatment at the four centres of excellence (JJ Hospital in Mumbai; GHTM Tambaram, Maulana Azad Medical College, New Delhi, and Calcutta School of Tropical Medicines, Kolkata). This pilot initiative would be studied for three months, after which a progress report would be submitted to the Court along with a plan for phase II.
The Court further stipulated that persons from anywhere in the country could be referred to these four centres, by first registering at the local ART centre and then being referred to the State AIDS Clinical Expert Panel in the centre of excellence. Finally, the Court concluded that the progress of each phase would depend largely on the number of individuals requiring treatment once access was provided, but that NACO should make its best to efforts to provide available universal treatment as early as possible.